The M‐Value, an Index of Blood‐sugar Control in Diabetics

Number of times cited according to CrossRef: 258

• Akira Matsumoto, Hirohito Kuwata, Shinichiro Kimura, Hiroko Matsumoto, Kozue Ochi, Yuki Moro-oka, Akiko Watanabe, Hironori Yamada, Hitoshi Ishii, Taiki Miyazawa, Siyuan Chen, Toshiaki Baba, Hiroshi Yoshida, Taichi Nakamura, Hiroshi Inoue, Yoshihiro Ogawa, Miyako Tanaka, Yuji Miyahara, Takayoshi Suganami, Hollow fiber-combined glucose-responsive gel technology as an in vivo electronics-free insulin delivery system, Communications Biology, 10.1038/s42003-020-1026-x, 3, 1, (2020).
  Crossref
• Yuko Nakamura, Mototsugu Nagao, Shunsuke Kobayashi, Takeshi Oba, Yuki Shuto, Izumi Fukuda, Shinichi Oikawa, Hitoshi Sugihara, Insulin and heparin challenge tests are useful for choosing an optimal insulin regimen in a case of subcutaneous insulin resistance, Journal of Diabetes Investigation, 10.1111/jdi.13266, 11, 5, (1370-1373), (2020).
  Wiley Online Library
• Yukiko Goshima, Yosuke Okada, Keiichi Torimoto, Yoshihisa Fujino, Yoshiya Tanaka, Changes in endothelial function during educational hospitalization and the contributor to improvement of endothelial function in type 2 diabetes mellitus, Scientific Reports, 10.1038/s41598-020-72341-8, 10, 1, (2020).
  Crossref
• Lino Scarpioni, Sergio Ballocchi, Aurelio Castelli, Roberto Scarpioni, Insulin Therapy in Uremic Diabetic Patients on Continuous Ambulatory Peritoneal Diaysis; Comparison of Intraperitoneal and Subcutaneous Administration, Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis, 10.1177/089686089401400206, 14, 2, (1-5), (2020).
  Crossref
• Michelle Nguyen, Julia Han, Elias K Spanakis, Boris Kovatchev, David C. Klonoff, A Review of Continuous Glucose Monitoring Based Composite Metrics for Glycemic Control, Diabetes Technology & Therapeutics, 10.1089/dia.2019.0434, (2020).
  Crossref
• Marie Mathilde Bjerg Christensen, Eva Elisabeth Hommel, Marit Eika Jørgensen, Jesper Fleischer, Christian Stevns Hansen, Glycemic Variability and Diabetic Neuropathy in Young Adults With Type 1 Diabetes, Frontiers in Endocrinology, 10.3389/fendo.2020.00644, 11, (2020).
  Crossref
• Vanessa Moscardó, Marga Giménez, Nick Oliver, Nathan R. Hill, Updated Software for Automated Assessment of Glucose Variability and Quality of Glycemic Control in Diabetes, Diabetes Technology & Therapeutics, 10.1089/dia.2019.0416, (2020).
  Crossref
• Vanessa Moscardó, Pau Herrero, Monika Reddy, Nathan Hill, Pantelis Georgiou, Nick Oliver, Assessment of Glucose Control Metrics by Discriminant Ratio, Diabetes Technology & Therapeutics, 10.1089/dia.2019.0415, (2020).
  Crossref
• H. Makino, A. Tanaka, K. Asakura, R. Koezuka, M. Tochiya, Y. Ohata, T. Tamanaha, C. Son, Y. Shimabara, T. Fujita, Y. Miyamoto, J. Kobayashi, K. Hosoda, Addition of low‐dose liraglutide to insulin therapy is useful for glycaemic control during the peri‐operative period: effect of glucagon‐like peptide‐1 receptor agonist therapy on glycaemic control in patients undergoing cardiac surgery (GLOLIA study), Diabetic Medicine, 10.1111/dme.14084, 36, 12, (1621-1628), (2019).
  Wiley Online Library
• Ji Hee Yu, Kyungdo Han, Sanghyun Park, Da Young Lee, Ga Eun Nam, Ji A Seo, Sin Gon Kim, Sei Hyun Baik, Yong Gyu Park, Seon Mee Kim, Nan Hee Kim, Kyung Mook Choi, Effects of long-term glycemic variability on incident cardiovascular disease and mortality in subjects without diabetes, Medicine, 10.1097/MD.0000000000016317, 98, 29, (e16317), (2019).
  Crossref
• Lalantha Leelarathna, Hood Thabit, Malgorzata E. Wilinska, Lia Bally, Julia K. Mader, Thomas R. Pieber, Carsten Benesch, Sabine Arnolds, Terri Johnson, Lutz Heinemann, Norbert Hermanns, Mark L. Evans, Roman Hovorka, Evaluating Glucose Control With a Novel Composite Continuous Glucose Monitoring Index, Journal of Diabetes Science and Technology, 10.1177/1932296819838525, (193229681983852), (2019).
  Crossref
• Enrico Longato, Giada Acciaroli, Andrea Facchinetti, Alberto Maran, Giovanni Sparacino, Simple Linear Support Vector Machine Classifier Can Distinguish Impaired Glucose Tolerance Versus Type 2 Diabetes Using a Reduced Set of CGM-Based Glycemic Variability Indices, Journal of Diabetes Science and Technology, 10.1177/1932296819838856, (193229681983885), (2019).
  Crossref
• fei zheng, Manon Jalbert, Florence Forbes, Stéphane Bonnet, Anne Wojtusciszyn, Sandrine LABLANCHE, Pierre Yves Benhamou, Characterization of Daily Glycemic Variability in Subjects with Type 1 Diabetes Using A Mixture of Metrics, Diabetes Technology & Therapeutics, 10.1089/dia.2019.0250, (2019).
  Crossref
• Boris Kovatchev, Glycemic Variability: Risk Factors, Assessment, and Control, Journal of Diabetes Science and Technology, 10.1177/1932296819826111, (193229681982611), (2019).
  Crossref
• Yi-Hsuan Lin, Yu-Yao Huang, Hsin-Yun Chen, Sheng-Hwu Hsieh, Jui-Hung Sun, Szu-Tah Chen, Chia-Hung Lin, Impact of Carbohydrate on Glucose Variability in Patients with Type 1 Diabetes Assessed Through Professional Continuous Glucose Monitoring: A Retrospective Study, Diabetes Therapy, 10.1007/s13300-019-00707-x, (2019).
  Crossref
• Suresh Rama Chandran, Robert Vigersky, Andreas Thomas, Lee Ling Lim, Jeyakantha Ratnasingam, Alexander Tan, Daphne S L Gardner, Role of composite glycemic indices: A comparison of the Comprehensive Glucose Pentagon (CGP) across diabetes types and HbA1c levels., Diabetes Technology & Therapeutics, 10.1089/dia.2019.0277, (2019).
  Crossref
• Hiroshi Bando, Koji Ebe, Tetsuo Muneta, Masahiro Bando, Yoshikazu Yonei, Difference of Glucose variability between Low Carbohydrate Diet (LCD) and Calorie Restriction (CR), Asploro Journal of Biomedical and Clinical Case Reports, 10.36502/2019/ASJBCCR.6142, 2, S1, (4-15), (2019).
  Crossref
• David Rodbard, Glucose Time-In-Range, Time-Above-Range, and Time-Below-Range Depend on Mean or Median Glucose or HbA1c, Glucose Coefficient of Variation (%CV), and Shape of the Glucose Distribution, Diabetes Technology & Therapeutics, 10.1089/dia.2019.0440, (2019).
  Crossref
• Nobuyuki Takahashi, Daisuke Chujo, Hiroshi Kajio, Kohjiro Ueki, Contribution of pancreatic α‐cell function to insulin sensitivity and glycemic variability in patients with type 1 diabetes, Journal of Diabetes Investigation, 10.1111/jdi.12949, 10, 3, (690-698), (2018).
  Wiley Online Library
• Enrico Longato, Giada Acciaroli, Andrea Facchinetti, Liisa Hakaste, Tiinamaija Tuomi, Alberto Maran, Giovanni Sparacino, Glycaemic variability-based classification of impaired glucose tolerance vs. type 2 diabetes using continuous glucose monitoring data, Computers in Biology and Medicine, 10.1016/j.compbiomed.2018.03.007, 96, (141-146), (2018).
  Crossref
• Débora Lopes Souto, Joana Rodrigues Dantas, Marcus Miranda Dos Santos Oliveira, Eliane Lopes Rosado, Ronir Raggio Luiz, Lenita Zajdenverg, Melanie Rodacki, Does sucrose affect the glucose variability in patients with type 1 diabetes? a pilot crossover clinical study, Nutrition, 10.1016/j.nut.2018.05.009, 55-56, (179-184), (2018).
  Crossref
• Koji Ebe, Hiroshi Bando, Tetsuo Muneta, Masahiro Bando, Yoshikazu Yonei, Homeostasis Model Assessment (HOMA) and M Value in Daily Profile of Glucose, POJ Clinical Case Reports, 10.32648/2639-3298/1/1/004, 1, 1, (1-7), (2018).
  Crossref
• Hiroshi Bando, Koji Ebe, Tetsuo Muneta, Masahiro Bando, Yoshikazu Yonei, Urinary C-Peptide Excretion for Diabetic Treatment in Low Carbohydrate Diet (LCD), Journal of Obesity and Diabetes, 10.33805/2638-812X.103, (13-18), (2018).
  Crossref
• Suresh Rama Chandran, Wei Lin Tay, Weng Kit Lye, Lee Ling Lim, Jeyakantha Ratnasingam, Alexander Tong Boon Tan, Daphne S.L. Gardner, Beyond HbA1c: Comparing Glycemic Variability and Glycemic Indices in Predicting Hypoglycemia in Type 1 and Type 2 Diabetes, Diabetes Technology & Therapeutics, 10.1089/dia.2017.0388, 20, 5, (353-362), (2018).
  Crossref
• L. Monnier, C. Colette, D. Owens, Glucose variability: Do we have to revisit the profusion of definitions to avoid confusion?, Diabetes & Metabolism, 10.1016/j.diabet.2017.10.005, 44, 2, (97-100), (2018).
  Crossref
• Y. F. Mo, W. Jia, Definition and Clinical Significance of Continuous Glucose Monitoring Parameters, Continuous Glucose Monitoring, 10.1007/978-981-10-7074-7, (47-63), (2018).
  Crossref
• Sophie Guilmin-Crépon, Jean-Claude Carel, Julien Schroedt, Erwan Scornet, Corinne Alberti, Nadia Tubiana-Rufi, How Should We Assess Glycemic Variability in Type 1 Diabetes? Contribution of Principal Component Analysis for Interstitial Glucose Indices in 142 Children, Diabetes Technology & Therapeutics, 10.1089/dia.2017.0404, 20, 6, (440-447), (2018).
  Crossref
• Oscar M. Muñoz, Ana María Gómez, García-Jaramillo Maira, Leon-Vargas Fabián Mauricio, Álvaro J. Ruiz-Morales, The different methods of assessing glycemic variability, quality of glycemic control and glycemic risk cannot be interpreted as equivalent in clinical practice, Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 10.1016/j.dsx.2018.03.028, 12, 4, (555-561), (2018).
  Crossref
• Xuefei Yu, Liangzhuo Lin, Jie Shen, Zhi Chen, Jun Jian, Bin Li, Sherman Xuegang Xin, Calculating the Mean Amplitude of Glycemic Excursions from Continuous Glucose Data Using an Open-Code Programmable Algorithm Based on the Integer Nonlinear Method, Computational and Mathematical Methods in Medicine, 10.1155/2018/6286893, 2018, (1-9), (2018).
  Crossref
• Kanta Fujimoto, Toshio Iwakura, Megumi Aburaya, Naoki Matsuoka, Twice-daily insulin degludec/insulin aspart effectively improved morning and evening glucose levels and quality of life in patients previously treated with premixed insulin: an observational study, Diabetology & Metabolic Syndrome, 10.1186/s13098-018-0366-x, 10, 1, (2018).
  Crossref
• David Rodbard, Metrics to Evaluate Quality of Glycemic Control: Comparison of Time in Target, Hypoglycemic, and Hyperglycemic Ranges with “Risk Indices”, Diabetes Technology & Therapeutics, 10.1089/dia.2017.0416, 20, 5, (325-334), (2018).
  Crossref
• Fumimaru Niwano, Yoshihisa Hiromine, Shinsuke Noso, Naru Babaya, Hiroyuki Ito, Sara Yasutake, Ippei Matsumoto, Yoshifumi Takeyama, Yumiko Kawabata, Hiroshi Ikegami, Insulin deficiency with and without glucagon: A comparative study between total pancreatectomy and type 1 diabetes, Journal of Diabetes Investigation, 10.1111/jdi.12799, 9, 5, (1084-1090), (2018).
  Wiley Online Library
• Kanta Fujimoto, Yui Shibayama, Eriko Yamaguchi, Sachiko Honjo, Akihiro Hamasaki, Yoshiyuki Hamamoto, Glucose excursions and hypoglycemia in patients with type 2 diabetes treated with mitiglinide/voglibose versus glimepiride: A randomized cross‐over trial, Journal of Diabetes, 10.1111/1753-0407.12658, 10, 8, (675-682), (2018).
  Wiley Online Library
• Takehiro Kanamori, Yumie Takeshita, Yuki Isobe, Ken-ichiro Kato, Hirofumi Misu, Shuichi Kaneko, Toshinari Takamura, Mealtime dosing of a rapid-acting insulin analog reduces glucose variability and suppresses daytime cardiac sympathetic activity: a randomized controlled study in hospitalized patients with type 2 diabetes, BMJ Open Diabetes Research & Care, 10.1136/bmjdrc-2018-000588, 6, 1, (e000588), (2018).
  Crossref
• Tae Jung Oh, Jae Myung Yu, Kyung Wan Min, Hyun Shik Son, Moon Kyu Lee, Kun Ho Yoon, Young Duk Song, Joong Yeol Park, In Kyung Jeong, Bong Soo Cha, Yong Seong Kim, Sei Hyun Baik, In Joo Kim, Doo Man Kim, Sung Rae Kim, Kwan Woo Lee, Jeong Hyung Park, In Kyu Lee, Tae Sun Park, Sung Hee Choi, Sung Woo Park, Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial, Diabetes & Metabolism Journal, 10.4093/dmj.2018.0051, 42, (2018).
  Crossref
• Yuiko Inaba, Chiharu Tsutsumi, Fumitaka Haseda, Reiko Fujisawa, Shinobu Mitsui, Hiroyuki Sano, Jungo Terasaki, Toshiaki Hanafusa, Akihisa Imagawa, Impact of glycemic variability on the levels of endothelial progenitor cells in patients with type 1 diabetes, Diabetology International, 10.1007/s13340-017-0335-x, 9, 2, (113-120), (2017).
  Crossref
• Giada Acciaroli, Giovanni Sparacino, Liisa Hakaste, Andrea Facchinetti, Giorgio Maria Di Nunzio, Alessandro Palombit, Tiinamaija Tuomi, Rafael Gabriel, Jaime Aranda, Saturio Vega, Claudio Cobelli, Diabetes and Prediabetes Classification Using Glycemic Variability Indices From Continuous Glucose Monitoring Data, Journal of Diabetes Science and Technology, 10.1177/1932296817710478, 12, 1, (105-113), (2017).
  Crossref
• Soichi Takeishi, Hiroki Tsuboi, Shodo Takekoshi, Comparison of morning basal + 1 bolus insulin therapy (insulin glulisine + insulin glargine 300 U/mL vs insulin lispro + insulin glargine biosimilar) using continuous glucose monitoring: A randomized crossover study, Journal of Diabetes Investigation, 10.1111/jdi.12661, 9, 1, (91-99), (2017).
  Wiley Online Library
• Mei Uemura, Yutaka Yano, Toshinari Suzuki, Taro Yasuma, Toshiyuki Sato, Aya Morimoto, Samiko Hosoya, Chihiro Suminaka, Hiromu Nakajima, Esteban C. Gabazza, Yoshiyuki Takei, Comparison of Glucose Area Under the Curve Measured Using Minimally Invasive Interstitial Fluid Extraction Technology with Continuous Glucose Monitoring System in Diabetic Patients, Diabetes & Metabolism Journal, 10.4093/dmj.2017.41.4.265, 41, 4, (265), (2017).
  Crossref
• Soichi Takeishi, Hiroki Tsuboi, Shodo Takekoshi, Comparison of tofogliflozin 20 mg and ipragliflozin 50 mg used together with insulin glargine 300 U/mL using continuous glucose monitoring (CGM): A randomized crossover study, Endocrine Journal, 10.1507/endocrj.EJ17-0206, 64, 10, (995-1005), (2017).
  Crossref
• John M. Lachin, Ionut Bebu, Richard M. Bergenstal, Rodica Pop-Busui, F. John Service, Bernard Zinman, David M. Nathan, Association of Glycemic Variability in Type 1 Diabetes With Progression of Microvascular Outcomes in the Diabetes Control and Complications Trial, Diabetes Care, 10.2337/dc16-2426, 40, 6, (777-783), (2017).
  Crossref
• M. Rodacki, R.M. Carvalho, L. Zajdenverg, The potential effect of ultra-long insulin degludec on glycemic variability, Diabetes Research and Clinical Practice, 10.1016/j.diabres.2017.06.003, 133, (92-103), (2017).
  Crossref
• Keiichi Torimoto, Yosuke Okada, Kenji Koikawa, Yoshiya Tanaka, Early effects of sodium-glucose co-transporter 2 inhibitors in type 2 diabetes: study based on continuous glucose monitoring, Diabetology & Metabolic Syndrome, 10.1186/s13098-017-0258-5, 9, 1, (2017).
  Crossref
• Boris P. Kovatchev, Metrics for glycaemic control — from HbA1c to continuous glucose monitoring, Nature Reviews Endocrinology, 10.1038/nrendo.2017.3, 13, 7, (425-436), (2017).
  Crossref
• Shingo Iwasaki, Junji Kozawa, Takekazu Kimura, Kenji Fukui, Hiromi Iwahashi, Akihisa Imagawa, Iichiro Shimomura, Insulin degludec is associated with less frequent and milder hypoglycemia in insulin-deficient patients with type 1 diabetes compared with insulin glargine or detemir, Diabetology International, 10.1007/s13340-017-0303-5, 8, 2, (228-236), (2017).
  Crossref
• Boris Kovatchev, Claudio Cobelli, Glucose Variability: Timing, Risk Analysis, and Relationship to Hypoglycemia in Diabetes, Diabetes Care, 10.2337/dc15-2035, 39, 4, (502-510), (2016).
  Crossref
• B. Bonora, A. Maran, S. Ciciliot, A. Avogaro, G. P. Fadini, Head-to-head comparison between flash and continuous glucose monitoring systems in outpatients with type 1 diabetes, Journal of Endocrinological Investigation, 10.1007/s40618-016-0495-8, 39, 12, (1391-1399), (2016).
  Crossref
• L. Monnier, C. Colette, S. Dejager, D. R. Owens, Near normal HbA1c with stable glucose homeostasis: the ultimate target/aim of diabetes therapy, Reviews in Endocrine and Metabolic Disorders, 10.1007/s11154-016-9325-8, 17, 1, (91-101), (2016).
  Crossref
• Akinori Hayashi, Koji Takano, Tsuguto Masaki, Sonomi Yoshino, Akifumi Ogawa, Masayoshi Shichiri, Distinct biomarker roles for HbA 1c and glycated albumin in patients with type 2 diabetes on hemodialysis, Journal of Diabetes and its Complications, 10.1016/j.jdiacomp.2016.08.015, 30, 8, (1494-1499), (2016).
  Crossref
• David Rodbard, Optimizing Display, Analysis, Interpretation and Utility of Self-Monitoring of Blood Glucose (SMBG) Data for Management of Patients with Diabetes, Journal of Diabetes Science and Technology, 10.1177/193229680700100111, 1, 1, (62-71), (2016).
  Crossref
• Michael Miller, Poul Strange, Use of Fourier Models for Analysis and Interpretation of Continuous Glucose Monitoring Glucose Profiles, Journal of Diabetes Science and Technology, 10.1177/193229680700100506, 1, 5, (630-638), (2016).
  Crossref
• Chiara Fabris, Andrea Facchinetti, Giuseppe Fico, Francesco Sambo, Maria Teresa Arredondo, Claudio Cobelli, Parsimonious Description of Glucose Variability in Type 2 Diabetes by Sparse Principal Component Analysis, Journal of Diabetes Science and Technology, 10.1177/1932296815596173, 10, 1, (119-124), (2015).
  Crossref
• Katarzyna Cypryk, Lukasz Bartyzel, Monika Zurawska-Klis, Wojciech Mlynarski, Agnieszka Szadkowska, Jan Wilczynski, Dorota Nowakowska, Lucyna A. Wozniak, Wojciech Fendler, Continuous Glucose Monitoring in Type 1 Diabetes Pregnancy Shows that Fetal Heart Rate Correlates with Maternal Glycemia, Diabetes Technology & Therapeutics, 10.1089/dia.2014.0255, 17, 9, (619-624), (2015).
  Crossref
• Jeannie Tay, Campbell H. Thompson, Grant D. Brinkworth, Glycemic Variability: Assessing Glycemia Differently and the Implications for Dietary Management of Diabetes, Annual Review of Nutrition, 10.1146/annurev-nutr-121214-104422, 35, 1, (389-424), (2015).
  Crossref
• Johannes Werzowa, Giovanni Pacini, Manfred Hecking, Catharina Fidler, Michael Haidinger, Helmut Brath, Andreas Thomas, Marcus D. Säemann, Andrea Tura, Comparison of glycemic control and variability in patients with type 2 and posttransplantation diabetes mellitus, Journal of Diabetes and its Complications, 10.1016/j.jdiacomp.2015.07.014, 29, 8, (1211-1216), (2015).
  Crossref
• Chia-Hung Lin, Daw-Ming Chang, Da-Jen Wu, Hui-Yu Peng, Lee-Ming Chuang, Assessment of Blood Glucose Regulation and Safety of Resistant Starch Formula-Based Diet in Healthy Normal and Subjects With Type 2 Diabetes, Medicine, 10.1097/MD.0000000000001332, 94, 33, (e1332), (2015).
  Crossref
• Jang-Won Son, In-Kyu Lee, Jeong-taek Woo, Sei Hyun Baik, Hak Chul Jang, Kwan Woo Lee, Bong Soo Cha, Yeon-Ah Sung, Tae Sun Park, Soon-Jib Yoo, Kun-Ho Yoon, A prospective, randomized, multicenter trial comparing the efficacy and safety of the concurrent use of long-acting insulin with mitiglinide or voglibose in patients with type 2 diabetes, Endocrine Journal, 10.1507/endocrj.EJ15-0325, 62, 12, (1049-1057), (2015).
  Crossref
• Yoshifumi Saisho, Chihiro Tanaka, Kumiko Tanaka, Rachel Roberts, Takayuki Abe, Masami Tanaka, Shu Meguro, Junichiro Irie, Toshihide Kawai, Hiroshi Itoh, Relationships among different glycemic variability indices obtained by continuous glucose monitoring, Primary Care Diabetes, 10.1016/j.pcd.2014.10.001, 9, 4, (290-296), (2015).
  Crossref
• Kei Fukami, Ryo Shibata, Hitomi Nakayama, Kentaro Yamada, Seiya Okuda, Masafumi Koga, Serum albumin-adjusted glycated albumin reflects glycemic excursion in diabetic patients with severe chronic kidney disease not treated with dialysis, Journal of Diabetes and its Complications, 10.1016/j.jdiacomp.2015.06.003, 29, 7, (913-917), (2015).
  Crossref
• Hye Seung Jung, Clinical Implications of Glucose Variability: Chronic Complications of Diabetes, Endocrinology and Metabolism, 10.3803/EnM.2015.30.2.167, 30, 2, (167), (2015).
  Crossref
• Jessica B. Wallaert, Sushela S. Chaidarun, Danielle Basta, Kathryn King, Richard Comi, Greg Ogrinc, Brian W. Nolan, Philip P. Goodney, Use of a Glucose Management Service Improves Glycemic Control Following Vascular Surgery: An Interrupted Time-Series Study, The Joint Commission Journal on Quality and Patient Safety, 10.1016/S1553-7250(15)41029-3, 41, 5, (221-AP1), (2015).
  Crossref
• Boris P. Kovatchev, Measures of Risk and Glucose Variability in Adults Versus Youths, Diabetes Technology & Therapeutics, 10.1089/dia.2015.0276, 17, 11, (766-769), (2015).
  Crossref
• Graham R. Law, George T.H. Ellison, Anna L. Secher, Peter Damm, Elisabeth R. Mathiesen, Rosemary Temple, Helen R. Murphy, Eleanor M. Scott, Analysis of Continuous Glucose Monitoring in Pregnant Women With Diabetes: Distinct Temporal Patterns of Glucose Associated With Large-for-Gestational-Age Infants, Diabetes Care, 10.2337/dc15-0070, 38, 7, (1319-1325), (2015).
  Crossref
• Giuseppe Derosa, Carmelo Libetta, Pasquale Esposito, Ilaria Borettaz, Carmine Tinelli, Angela D’Angelo, Pamela Maffioli, Bicarbonate dialysis compared to hemodiafiltration on glycemic excursions in patients with end-stage renal disease with and without type 2 diabetes mellitus, Journal of Diabetes and its Complications, 10.1016/j.jdiacomp.2015.08.009, 29, 8, (1136-1141), (2015).
  Crossref
• Yoshiki Kusunoki, Tomoyuki Katsuno, Rie Nakae, Kahori Watanabe, Takafumi Akagami, Fumihiro Ochi, Masaru Tokuda, Kazuki Murai, Masayuki Miuchi, Jun-ichiro Miyagawa, Mitsuyoshi Namba, Evaluation of blood glucose fluctuation in Japanese patients with type 1 diabetes mellitus by self-monitoring of blood glucose and continuous glucose monitoring, Diabetes Research and Clinical Practice, 10.1016/j.diabres.2015.01.040, 108, 2, (342-349), (2015).
  Crossref
• Shingo Iwasaki, Junji Kozawa, Kenji Fukui, Hiromi Iwahashi, Akihisa Imagawa, Iichiro Shimomura, Coefficient of variation of R-R interval closely correlates with glycemic variability assessed by continuous glucose monitoring in insulin-depleted patients with type 1 diabetes, Diabetes Research and Clinical Practice, 10.1016/j.diabres.2015.05.021, 109, 2, (397-403), (2015).
  Crossref
• David Rodbard, Clinical Interpretation of Indices of Quality of Glycemic Control and Glycemic Variability, Postgraduate Medicine, 10.3810/pgm.2011.07.2310, 123, 4, (107-118), (2015).
  Crossref
• Katsumi Iizuka, Hiroyuki Niwa, Youichi Takahashi, Jun Takeda, Liraglutide normalised glucose tolerance and the response of insulin to glucose in a non-obese patient with newly diagnosed type-2 diabetes mellitus, Diabetology International, 10.1007/s13340-014-0167-x, 5, 4, (254-259), (2014).
  Crossref
• Mitsuyoshi Takahara, Toshihiko Shiraiwa, Naoto Katakami, Taka-aki Matsuoka, Iichiro Shimomura, Efficacy of Adding Once-Daily Insulin Glulisine in Japanese Type 2 Diabetes Patients Treated with Insulin Glargine and Sitagliptin, Diabetes Technology & Therapeutics, 10.1089/dia.2014.0075, 16, 10, (633-639), (2014).
  Crossref
• Chiara Fabris, Andrea Facchinetti, Giovanni Sparacino, Mattia Zanon, Stefania Guerra, Alberto Maran, Claudio Cobelli, Glucose Variability Indices in Type 1 Diabetes: Parsimonious Set of Indices Revealed by Sparse Principal Component Analysis, Diabetes Technology & Therapeutics, 10.1089/dia.2013.0252, 16, 10, (644-652), (2014).
  Crossref
• Nam K. Tran, Zachary R. Godwin, Jennifer C. Bockhold, Anthony G. Passerini, Julian Cheng, Morgan Ingemason, Clinical Impact of Sample Interference on Intensive Insulin Therapy in Severely Burned Patients, Journal of Burn Care & Research, 10.1097/BCR.0b013e31829b3700, 35, 1, (72-79), (2014).
  Crossref
• Désordres glycémiques, Diabétologie, 10.1016/B978-2-294-73954-5.00004-4, (47-69), (2014).
  Crossref
• Piero Micossi, U. Raggi, F. Dosio, M. Scavini, A. Bertin, G. Pozza, Open-loop device Microjet MC 2 improves unstable diabetes, lowers the daily insulin requirement and reduces the excursions of plasma free insulin levels: comparison with a traditional intensive treatment, Journal of Endocrinological Investigation, 10.1007/BF03350606, 6, 3, (189-194), (2014).
  Crossref
• Yoshifumi Saisho, Glycemic Variability and Oxidative Stress: A Link between Diabetes and Cardiovascular Disease?, International Journal of Molecular Sciences, 10.3390/ijms151018381, 15, 10, (18381-18406), (2014).
  Crossref
• Guang Yang, Chunlin Li, Yanping Gong, Jian Li, Xiaoling Cheng, Hui Tian, A Prospective, Randomized, Open-Label Study Comparing the Efficacy and Safety of Preprandial and Prandial Insulin in Combination with Acarbose in Elderly, Insulin-Requiring Patients with Type 2 Diabetes Mellitus, Diabetes Technology & Therapeutics, 10.1089/dia.2012.0275, 15, 6, (513-519), (2013).
  Crossref
• F. J. Service, Glucose Variability, Diabetes, 10.2337/db12-1396, 62, 5, (1398-1404), (2013).
  Crossref
• Keiji Yoshioka, Haruhiko Isotani, Shin-ichiro Ohashi, Minoru Imamura, Efficacy of vildagliptin on glucose fluctuation in Japanese type 2 diabetic patients with ongoing sulfonylurea based oral glycemic agent therapy, Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 10.1016/j.dsx.2013.02.015, 7, 1, (32-34), (2013).
  Crossref
• HITOMI OGATA, KAZUTERU NAKAMURA, MAKI SATO, KUMPEI TOKUYAMA, SHOICHIRO NAGASAKA, NAOYUKI EBINE, KEN KIYONO, YOSHIHARU YAMAMOTO, Lack of Negative Correlation in Glucose Dynamics by Nonexercise Activity Thermogenesis Restriction in Healthy Adults, Medicine & Science in Sports & Exercise, 10.1249/MSS.0b013e31826c2dfc, 45, 1, (60-66), (2013).
  Crossref
• Noriko Kodani, Yoshifumi Saisho, Kumiko Tanaka, Toshihide Kawai, Hiroshi Itoh, Effects of Mitiglinide, a Short-Acting Insulin Secretagogue, on Daily Glycemic Variability and Oxidative Stress Markers in Japanese Patients with Type 2 Diabetes Mellitus, Clinical Drug Investigation, 10.1007/s40261-013-0098-5, 33, 8, (563-570), (2013).
  Crossref
• Chiharu Tsutsumi, Akihisa Imagawa, Mineki Onishi, Hiroyuki Sano, Seiko Nakagawa, Yuko Murase-Mishiba, Jungo Terasaki, Toshiaki Hanafusa, Glycated albumin as a useful clinical biomarker for glycemic variability in type 1 diabetes assessed by continuous glucose monitoring, Diabetology International, 10.1007/s13340-013-0108-0, 4, 3, (156-159), (2013).
  Crossref
• Satoru Yamada, Ryo Hirai, Gaku Inoue, Yoshifumi Yamada, Junichiro Irie, Koichiro Atsuda, Toshikazu Yamanouchi, Comparison of glycemic variability between basal-bolus and premixed insulin therapy, Journal of Diabetes Mellitus, 10.4236/jdm.2013.32008, 03, 02, (45-51), (2013).
  Crossref
• Seiya Shimoda, Shinsuke Iwashita, Shinji Ichimori, Yasuto Matsuo, Rieko Goto, Takako Maeda, Tomoko Matsuo, Taiji Sekigami, Junji Kawashima, Tatsuya Kondo, Takeshi Matsumura, Hiroyuki Motoshima, Noboru Furukawa, Kenro Nishida, Eiichi Araki, Efficacy and safety of sitagliptin as add-on therapy on glycemic control and blood glucose fluctuation in Japanese type 2 diabetes subjects ongoing with multiple daily insulin injections therapy, Endocrine Journal, 10.1507/endocrj.EJ13-0198, 60, 10, (1207-1214), (2013).
  Crossref
• Satoshi Dote, Maki Sawai, Takeshi Hattori, Ayumu Nozaki, Yuka Kobayashi, Shoichi Doi, Toshiko Shingu, Hirokazu Nakanishi, Blood Glucose Management in Steroid Therapy for Hematologic Malignancies Complicated by Diabetes:, Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences), 10.5649/jjphcs.39.395, 39, 7, (395-405), (2013).
  Crossref
• J.-V. Schaal, N. Libert, S. De Rudnicki, Y. Auroy, S. Mérat, La variabilité glycémique en réanimation, Annales Françaises d'Anesthésie et de Réanimation, 10.1016/j.annfar.2012.09.002, 31, 12, (950-960), (2012).
  Crossref
• F. Picconi, A. Di Flaviani, I. Malandrucco, I. Giordani, S. Frontoni, Impact of glycemic variability on cardiovascular outcomes beyond glycated hemoglobin. Evidence and clinical perspectives, Nutrition, Metabolism and Cardiovascular Diseases, 10.1016/j.numecd.2012.03.006, 22, 9, (691-696), (2012).
  Crossref
• Julie Wagner, Howard Tennen, Howard Wolpert, Continuous Glucose Monitoring, Psychosomatic Medicine, 10.1097/PSY.0b013e31825769ac, 74, 4, (356-365), (2012).
  Crossref
• Katsumi Iizuka, Reiko Tomita, Yukio Horikawa, Jun Takeda, A case of glycemic instability and insulin allergy due to anti-insulin antibodies in a patient with type 2 diabetes, Diabetology International, 10.1007/s13340-012-0077-8, 3, 4, (233-238), (2012).
  Crossref
• Alma Prieto-Tenreiro, Rocío Villar-Taibo, Marcos Pazos-Couselo, María González-Rodríguez, Felipe Casanueva, José Manuel García-López, Benefits of subcutaneous continuous insulin infusion in type 1 diabetic patients with high glycemic variability, Endocrinología y Nutrición (English Edition), 10.1016/j.endoen.2012.04.013, 59, 4, (246-253), (2012).
  Crossref
• Alma Prieto-Tenreiro, Rocío Villar-Taibo, Marcos Pazos-Couselo, María González-Rodríguez, Felipe Casanueva, José Manuel García-López, Beneficios de la terapia con infusión subcutánea continua de insulina en pacientes diabéticos tipo 1 que presentan gran variabilidad glucémica, Endocrinología y Nutrición, 10.1016/j.endonu.2012.02.005, 59, 4, (246-253), (2012).
  Crossref
• Mitsuyoshi Takahara, Toshihiko Shiraiwa, Hideaki Kaneto, Naoto Katakami, Taka-aki Matsuoka, Iichiro Shimomura, Efficacy of sitagliptin on blood glucose fluctuation in Japanese type 2 diabetic patients with basal-supported oral therapy, Endocrine Journal, 10.1507/endocrj.EJ12-0220, 59, 12, (1131-1136), (2012).
  Crossref
• Rhonda VanDyke, Yan Ren, Heidi J. Sucharew, Menachem Miodovnik, Barak Rosenn, Jane C. Khoury, Characterizing maternal glycemic control: a more informative approach using semiparametric regression, The Journal of Maternal-Fetal & Neonatal Medicine, 10.3109/14767058.2012.626922, 25, 1, (15-19), (2011).
  Crossref
• M. Takita, S. Matsumoto, M. Shimoda, D. Chujo, T. Itoh, S. Iwahashi, J.A. SoRelle, N. Onaca, B. Naziruddin, M.F. Levy, Association Between the Secretory Unit of Islet Transplant Objects Index and Satisfaction With Insulin Therapy Among Insulin-Dependent Islet Recipients, Transplantation Proceedings, 10.1016/j.transproceed.2011.10.029, 43, 9, (3250-3255), (2011).
  Crossref
• Susan L. Johnson, Laura N. McEwen, Christopher A. Newton, Catherine L. Martin, Philip Raskin, Jeffrey B. Halter, William H. Herman, The impact of continuous subcutaneous insulin infusion and multiple daily injections of insulin on glucose variability in older adults with type 2 diabetes, Journal of Diabetes and its Complications, 10.1016/j.jdiacomp.2010.09.005, 25, 4, (211-215), (2011).
  Crossref
• Nathan R. Hill, Nick S. Oliver, Pratik Choudhary, Jonathan C. Levy, Peter Hindmarsh, David R. Matthews, Normal Reference Range for Mean Tissue Glucose and Glycemic Variability Derived from Continuous Glucose Monitoring for Subjects Without Diabetes in Different Ethnic Groups, Diabetes Technology & Therapeutics, 10.1089/dia.2010.0247, 13, 9, (921-928), (2011).
  Crossref
• Achilleas N. Pitsillides, Stacey M. Anderson, Boris Kovatchev, Hypoglycemia Risk and Glucose Variability Indices Derived from Routine Self-Monitoring of Blood Glucose Are Related to Laboratory Measures of Insulin Sensitivity and Epinephrine Counterregulation, Diabetes Technology & Therapeutics, 10.1089/dia.2010.0103, 13, 1, (11-17), (2011).
  Crossref
• Renata A. Rawlings, Hang Shi, Lo-Hua Yuan, William Brehm, Rodica Pop-Busui, Patrick W. Nelson, Translating Glucose Variability Metrics into the Clinic via C ontinuous G lucose M onitoring: A G raphical U ser I nterface for D iabetes E valuation (CGM-GUIDE © ) , Diabetes Technology & Therapeutics, 10.1089/dia.2011.0099, 13, 12, (1241-1248), (2011).
  Crossref
• Benjamin C. Whitelaw, Pratik Choudhary, David Hopkins, Evaluating Rate of Change as an Index of Glycemic Variability, Using Continuous Glucose Monitoring Data, Diabetes Technology & Therapeutics, 10.1089/dia.2010.0215, 13, 6, (631-636), (2011).
  Crossref
• E. Moberg, M. Kollind, P-E. Lins, U. Adamson, Estimation of blood-glucose variability in patients with insulin-dependent diabetes mellitus, Scandinavian Journal of Clinical and Laboratory Investigation, 10.1080/00365519309092547, 53, 5, (507-514), (2011).
  Crossref
• Joseph R. Rausch, Measures of Glycemic Variability and Links with Psychological Functioning, Current Diabetes Reports, 10.1007/s11892-010-0152-0, 10, 6, (415-421), (2010).
  Crossref
• Sarah E. Siegelaar, Frits Holleman, Joost B. L. Hoekstra, J. Hans DeVries, Glucose Variability; Does It Matter?, Endocrine Reviews, 10.1210/er.2009-0021, 31, 2, (171-182), (2010).
  Crossref
• See more